EGFR-mutated tumours also tended to have peripheral lesions (p = 0.035) and GGOs (p < 0.001), especially mixed GGOs (mGGOs) (p = 0.045), well-defined margins (p = 0.022), air bronchograms (p < 0.001), pleural retraction (p < 0.001) and no lymphadenopathy (p = 0.001) (Fig. 2). This evidence concerns the gene EGFR and neoplasm.